Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Ebbers E, Ariaans GJ, Zwanenburg B, Bruggink A. Controlled design of resolutions. Prediction of the efficiency of resolutions based on samples of arbitrary composition. ACTA ACUST UNITED AC 1998. [DOI: 10.1016/s0957-4166(98)00280-8] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]

For:	Ebbers E, Ariaans GJ, Zwanenburg B, Bruggink A. Controlled design of resolutions. Prediction of the efficiency of resolutions based on samples of arbitrary composition. ACTA ACUST UNITED AC 1998. [DOI: 10.1016/s0957-4166(98)00280-8] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]

Number

Cited by Other Article(s)

Tilborg A, Springuel G, Norberg B, Wouters J, Leyssens T. On the influence of using a zwitterionic coformer for cocrystallization: structural focus on naproxen–proline cocrystals. CrystEngComm 2013. [DOI: 10.1039/c3ce40084k] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]

He Q, Rohani S, Zhu J, Gomaa H. Resolution of sertraline with (R)-mandelic acid: Chiral discrimination mechanism study. Chirality 2011;24:119-28. [DOI: 10.1002/chir.21033] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2010] [Accepted: 08/10/2011] [Indexed: 11/10/2022]

Pham XH, Kim JM, Chang SM, Kim IH, Kim WS. Enantioseparation of D/L-mandelic acid with L-phenylalanine in diastereomeric crystallization. ACTA ACUST UNITED AC 2009. [DOI: 10.1016/j.molcatb.2008.12.023] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]

Mizobe Y, Hinoue T, Yamamoto A, Hisaki I, Miyata M, Hasegawa Y, Tohnai N. Systematic Investigation of Molecular Arrangements and Solid-State Fluorescence Properties on Salts of Anthracene-2,6-disulfonic Acid with Aliphatic Primary Amines. Chemistry 2009;15:8175-84. [DOI: 10.1002/chem.200900773] [Citation(s) in RCA: 71] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]

Rossi F, Corcella F, Caldarelli FS, Heidempergher F, Marchionni C, Auguadro M, Cattaneo M, Ceriani L, Visentin G, Ventrella G, Pinciroli V, Ramella G, Candiani I, Bedeschi A, Tomasi A, Kline BJ, Martinez CA, Yazbeck D, Kucera DJ. Process Research and Development and Scale-up of a 4,4-Difluoro-3,3-dimethylproline Derivative. Org Process Res Dev 2008. [DOI: 10.1021/op7001112] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]

Affiliation(s)

Francesco Rossi Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
Francesco Corcella Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
Francesco Saverio Caldarelli Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
Franco Heidempergher Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
Chiara Marchionni Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
Miriam Auguadro Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
Marco Cattaneo Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
Lucio Ceriani Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
Giuseppina Visentin Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
Giambattista Ventrella Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
Vittorio Pinciroli Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
Giuliano Ramella Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
Ilaria Candiani Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
Angelo Bedeschi Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
Attilio Tomasi Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
Billie J. Kline Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
Carlos A. Martinez Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
Daniel Yazbeck Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A
David J. Kucera Active Pharmaceutical Ingredients and Analytical Development & Quality Control, Nerviano Medical Sciences, Pharmaceutical Sciences Unit Viale Pasteur 10, 20014 Nerviano, Italy, and Chemical Research and Development, La Jolla Laboratories, Pfizer Inc., 10578 Science Center Drive, San Diego, California 92121-1111, U.S.A

Collapse

Smith AA, McKay B, Damen EWP, Darphorn-Hooijschuur S, Ras EJ, Verspui G. Prediction of Maximum Yield in the Crystallization of Multicomponent Isomeric Systems. Org Process Res Dev 2006. [DOI: 10.1021/op060153s] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]

Rational approach to the selection of conditions for diastereomeric resolution of chiral amines by diacid resolving agents. ACTA ACUST UNITED AC 2006. [DOI: 10.1016/j.tetasy.2006.04.036] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]

Sada K, Inoue K, Tanaka T, Epergyes A, Tanaka A, Tohnai N, Matsumoto A, Miyata M. Multicomponent Organic Alloys Based on Organic Layered Crystals. Angew Chem Int Ed Engl 2005;44:7059-62. [PMID: 16222649 DOI: 10.1002/anie.200501678] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]

Sada K, Inoue K, Tanaka T, Epergyes A, Tanaka A, Tohnai N, Matsumoto A, Miyata M. Multicomponent Organic Alloys Based on Organic Layered Crystals. Angew Chem Int Ed Engl 2005. [DOI: 10.1002/ange.200501678] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]

Müller S, Ariaans GJ, Kaptein B, Broxterman QB, Bruggink A. Phase diagrams of diastereomeric pairs in inclusion resolution. ACTA ACUST UNITED AC 2005. [DOI: 10.1016/j.tetasy.2005.07.006] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]

Marchand P, Lefèbvre L, Querniard F, Cardinaël P, Perez G, Counioux JJ, Coquerel G. Diastereomeric resolution rationalized by phase diagrams under the actual conditions of the experimental process. ACTA ACUST UNITED AC 2004. [DOI: 10.1016/j.tetasy.2004.06.044] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]